Journal of the Association of Nurses in AIDS Care
Volume 20, Issue 4 , Pages 260-274 , July 2009

HIV Infection and Obesity: A Review of the Evidence

References 

  1. Albu JB, Kenya S, He Q, Wainwright M, Berk ES, Heshka S, et al. Independent associations of insulin resistance with high whole-body intermuscular and low leg subcutaneous adipose tissue distribution in obese HIV-infected women. American Journal of Clinical Nutrition. 2007;86:100–106
  2. Amorosa V, Synnestvedt M, Gross R, Friedman H, MacGregor RR, Gudonis D, et al. A tale of 2 epidemics: The intersection between obesity and HIV infection in Philadelphia. Journal of Acquired Immune Deficiency Syndromes. 2005;39:557–561
  3. Bjorntorp P. The regulation of adipose tissue distribution in humans. International Journal of Obesity and Related Metabolic Disorders. 1996;20(4):291–302
  4. Blass SC, Ellinger S, Vogel M, Ingiliz P, Spengler U, Stehle P, et al. Overweight HIV patients with abdominal fat distribution treated with protease inhibitors are at high risk for abnormalities in glucose metabolism: A reason for glycemic control. European Journal of Medical Research. 2008;13:209–214
  5. Brar I, Shuter J, Thomas A, Daniels E, Absalon J Minorities and Women's Task Force of Terry Beirn Community Programs for Clinical Research on AIDS. A comparison of factors associated with prevalent diabetes mellitus among HIV-infected antiretroviral-naive individuals versus individuals in the national health and nutritional examination survey cohort. Journal of Acquired Immune Deficiency Syndromes. 2007;45:66–71
  6. Carr A, Samaras K, Burton S, Law M, Freund J, Chisholhm D, et al. A syndrome of peripheral lipodystrophy, hyperlipidemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS. 1998;14:F25–F32
  7. Centers for Disease Control and Prevention . Adult participation in recommended levels of physical activity—United States, 2001 and 2003. Morbidity Mortality Weekly Report. 2005;54:1208–1212
  8. Currier JS, Lundgren JD, Carr A, Klein D, Sabin CA, Sax PE, et al. Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy. Circulation. 2008;118:e29–e35
  9. Danoff A, Shi Q, Justman J, Mulligan K, Hessol N, Robison E, et al. Oral glucose tolerance and insulin sensitivity are unaffected by HIV infection or antiretroviral therapy in overweight women. Journal of Acquired Immune Deficiency Syndromes. 2005;39:55–62
  10. Dreschler H, Powderly WG. Switching effective antiretroviral therapy: A review. Clinical Infectious Diseases. 2002;35:1219–1230
  11. Engleson ES, Kotler DP, Tan Y, Agin D, Wang J, Pierson RN, et al. Fat distribution in HIV-infected patients reporting truncal enlargement quantified by whole-body magnetic resonance imaging. American Journal of Clinical Nutrition. 1999;69:1162–1169
  12. Falutz J, Allas S, Blot K, Potvin D, Kotler D, Somero M, et al. Metabolic effects of a growth hormone-releasing factor in patients with HIV. New England Journal of Medicine. 2007;357:2359–2370
  13. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among U.S. adults. Journal of the American Medical Association. 2002;287:356–359
  14. Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation. 2004;109:433–438
  15. Hadigan C, Meigs JB, Corcoran C, Rietschel P, Piecuch S, Basgoz N, et al. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clinical Infectious Diseases. 2001;32:130–139
  16. Hadigan C, Meigs JB, Wilson PW, D'Agostino RB, Davis B, Basgoz N, et al. Prediction of coronary heart disease risk in HIV-infected patients with fat redistribution. Clinical Infectious Diseases. 2003;36:909–916
  17. Hadigan C, Miller K, Corcoran C, Anderson E, Basgoz N, Grinspoon S. Fasting hyperinsulinemia and changes in regional body composition in human immunodeficiency virus-infected women. Journal of Clinical Endocrinology & Metabolism. 1999;84:1932–1937
  18. Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA, et al. Physical activity and public health: Updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Medicine and Science in Sports Exercise. 2007;39:1423–1434
  19. Heath KV, Hogg RS, Singer J, Chan KJ, O'Shaughnessy MW, Montaner JS. Antiretroviral treatment patterns and incident HIV-associated morphologic and lipid abnormalities in a population-based cohort. Journal of Acquired Immune Deficiency Syndrome. 2002;30:440–447
  20. Hendricks KM, Willis K, Houser R, Jones CY. Obesity in HIV-infection: Dietary correlates. Journal of the American College of Nutrition. 2006;25:321–331
  21. Hodgson LM, Ghattas H, Pritchitt H, Schwenk A, Payne L, Macallan DC. Wasting and obesity in HIV outpatients. AIDS. 2001;15:2341–2342
  22. Hollis JF, Gullion CM, Stevens VJ, Brantley PJ, Appel LJ, Ard JD, et al. Weight loss during the intensive intervention phase of the weight-loss maintenance trial. American Journal of Preventive Medicine. 2008;35:118–126
  23. Innes KE, Vincent HK, Taylor AG. Chronic stress and insulin resistance-related indices of cardiovascular disease risk, part 2: A potential role for mind-body therapies. Alternative Therapies in Health and Medicine. 2007;13:44–51
  24. Jacobson DL, Tang AM, Spiegelman D, Thomas AM, Skinner S, Gorbach SL, et al. Incidence of metabolic syndrome in a cohort of HIV-infected adults and prevalence relative to the U.S. population. Journal of Acquired Immune Deficiency Syndromes. 2006;43:458–466
  25. Jones CY, Hogan JW, Snyder B, Klein RS, Rompalo A, Schuman P, et al. Overweight and human immunodeficiency virus (HIV) progression in women: Associations between HIV disease progression and changes in body mass index in women in the HIV epidemiology research study cohort. Clinical Infectious Diseases. 2003;37(Suppl. 2):S69–S80
  26. Jones CY, Wilson IB, Greenberg AS, Shevitz A, Knox TA, Gorbach SL, et al. Insulin resistance in HIV-infected men and women in the nutrition for healthy living cohort. Journal of Acquired Immune Deficiency Syndromes. 2005;40:202–211
  27. Justman JE, Hoover DR, Shi Q, Tan T, Anastos K, Tien PC, et al. Longitudinal anthropometric patterns among HIV-infected and HIV-uninfected women. Journal of Acquired Immune Deficiency Syndromes. 2008;47:312–319
  28. Kaplan RC, Kingsley LA, Sharrett AR, Li X, Lazar J, Tien PC, et al. Ten-year predicted coronary heart disease risk in HIV-infected men and women. Clinical Infectious Diseases. 2007;45:1074–1081
  29. Khunnawat C, Mukerji S, Havlichek D, Touma R, Abela GS. Cardiovascular manifestations in human immunodeficiency virus-infected patients. American Journal of Cardiology. 2008;102:635–642
  30. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine. 2002;364:393–403
  31. Kohli R, Shevitz A, Gorbach S, Wanke C. A randomized placebo-controlled trial of metformin for the treatment of HIV lipodystrophy. HIV Medicine. 2007;8:420–426
  32. Kotler DP, Rosenbaum K, Wang J, Pierson RN. Studies of body composition and fat distribution in HIV-infected and control subjects. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology. 1999;20:228–237
  33. Kumanyika SK, Obarzenek E, Stettler N, Bell R, Field AE, Fortmann SP, et al. Population-based prevention of obesity: The need for comprehensive promotion of healthful eating, physical activity, and energy balance. Circulation. 2008;118:428–464
  34. Lin B, Guthrie JE. Nutrient contribution of food away from home. Washington, DC: U.S. Department of Agriculture, Economic Research Service; 1999;
  35. Lo J, You SM, Canavan B, Liebau J, Beltrani G, Koutkia P, et al. Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation: A randomized controlled trial. Journal of the American Medical Association. 2008;300:509–519
  36. Mondy K, Overton ET, Grubb J, Tong S, Seyfried W, Powderly W, et al. Metabolic syndrome in HIV-infected patients from an urban, midwestern U.S. outpatient population. Clinical Infectious Diseases. 2007;44:726–734
  37. Moyle GJ. Plastic surgical approaches for HIV-associated lipoatrophy. Current HIV/AIDS Reports. 2005;2:127–131
  38. Mu H, Chai H, Lin P, Yao Q, Chen C. Current update on HIV-associated vascular disease and endothelial dysfunction. World Journal of Surgery. 2007;31:632–643
  39. National Heart, Lung, and Blood Institute Education Initiative . The practical guide: Identification, evaluation, and treatment of overweight and obesity in adults. Washington, DC: National Institutes of Health; 2000;
  40. National Heart, Lung, and Blood Institute. (2008). Portion distortion. Retrieved September 23, 2008, from http://hp2010.nhlbihin.net/portion/
  41. Nieuwenhuizen AG, Rutters F. The hypothalamic-pituitary-adrenal-axis in the regulation of energy balance. Physiology and Behavior. 2008;94:69–177
  42. O'Brien K, Nixon S, Glazier RH, Tynan AM. Progressive resistive exercise interventions for adults living with HIV/AIDS. Cochrane Database of Systematic Reviews. 2007;2:
  43. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. Journal of the American Medical Association. 2006;295:1549–1555
  44. Pao V, Lee GA, Grunfeld C. HIV therapy, metabolic syndrome, and cardiovascular risk. Current Atherosclerosis Reports. 2008;10:61–70
  45. Samaras K, Wand H, Law M, Emery S, Cooper D, Carr A. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria. Diabetes Care. 2007;30:113–119
  46. Shai I, Schwarzfuch D, Henkin Y, Shahar D, Witkow S, Greenberg I, et al. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. The New England Journal of Medicine. 2008;359:229–241
  47. Shaw K, O'Rourke P, Del Mar C, Kenardy J. Psychological interventions for overweight or obesity. Cochrane Database of Systematic Reviews, 2, CD003818. 2005;
  48. Shevitz, A.H., & Knox, T.A. (2001). Nutrition in the era of highly active antiretroviral therapy. Clinical Infectious Diseases, 32, 1769–1775. Erratum in Clinical Infectious Diseases, 33, 1445.
  49. Shor-Posner G, Campa A, Zhang G, Persaud N, Miguez-Burbano MJ, Quesada J, et al. When obesity is desirable: A longitudinal study of the Miami HIV-1-infected drug abusers (MIDAS) cohort. Journal of Acquired Immune Deficiency Syndromes. 2000;23:81–88
  50. Shuter J, Chang CJ, Klein RS. Prevalence and predictive value of overweight in an urban HIV care clinic. Journal of Acquired Immune Deficiency Syndromes. 2001;26:291–297
  51. Tang AM, Jacobson DL, Spiegelman D, Knox TA, Wanke C. Increasing risk of 5% or greater unintentional weight loss in a cohort of HIV-infected patients, 1995 to 2003. Journal of Acquired Immune Deficiency Syndromes. 2005;40:70–76
  52. Torres SJ, Nowson CA. Relationship between stress, eating behavior, and obesity. Nutrition. 2007;23:887–894
  53. Wohl DA, McComsey G, Tebas P, Brown TT, Glesby MJM, Reeds D, et al. Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy. HIV/AIDS. 2006;43:645–653
  54. World Health Organization. (1999). Definition, diagnosis and classification of diabetes mellitus and its complications: Report of a WHO consultation. Part 1: Diagnosis and classification of diabetes mellitus. Retrieved September 20, 2008, from http://www.staff.ncl.ac.uk/philip.home/who_dmc.htm

PII: S1055-3290(09)00071-5

doi: 10.1016/j.jana.2009.02.006

Journal of the Association of Nurses in AIDS Care
Volume 20, Issue 4 , Pages 260-274 , July 2009

Article Tools